DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients (2017)
- Authors:
- Ribeiro, Renata Scopim
- Machado Neto, João Agostinho
- Campos, Paula De Melo - Universidade Estadual de Campinas (UNICAMP)
- Eide, Christopher A.
- Savage, Samantha L.
- Lorand-Metze, Irene - Universidade Estadual de Campinas (UNICAMP)
- Tognon, Cristina E.
- Costa, Fernando Ferreira - Universidade Estadual de Campinas (UNICAMP)
- Druker, Brian J.
- Saad, Sara Teresinha Olalla - Universidade Estadual de Campinas (UNICAMP)
- Traina, Fabiola
- USP affiliated authors: MACHADO NETO, JOÃO AGOSTINHO - ICB ; TRAINA, FABÍOLA - FMRP
- Unidades: ICB; FMRP
- Subjects: NEOPLASIAS; DOENÇAS HEMATOLÓGICAS; LEUCEMIA
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2017
- Source:
- Conference titles: Annual meeting and Exposition of American Society of Hematology (ASH)
-
ABNT
RIBEIRO, Renata Scopim et al. DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: http://www.bloodjournal.org/content/130/Suppl_1/3969. Acesso em: 11 fev. 2026. , 2017 -
APA
Ribeiro, R. S., Machado Neto, J. A., Campos, P. D. M., Eide, C. A., Savage, S. L., Lorand-Metze, I., et al. (2017). DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Recuperado de http://www.bloodjournal.org/content/130/Suppl_1/3969 -
NLM
Ribeiro RS, Machado Neto JA, Campos PDM, Eide CA, Savage SL, Lorand-Metze I, Tognon CE, Costa FF, Druker BJ, Saad STO, Traina F. DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients [Internet]. Blood. 2017 ; 130[citado 2026 fev. 11 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/3969 -
Vancouver
Ribeiro RS, Machado Neto JA, Campos PDM, Eide CA, Savage SL, Lorand-Metze I, Tognon CE, Costa FF, Druker BJ, Saad STO, Traina F. DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients [Internet]. Blood. 2017 ; 130[citado 2026 fev. 11 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/3969 - De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
- Stathmin 1 expression in plasma cell neoplasms. [Carta]
- Increased levels of cyclin D1 negatively impacts on acute lymphoblastic leukemia overall survival
- Effects of RhoA and RhoC upon the sensitivity of prostate cancer cells to glutamine deprivation
- IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes. [Carta]
- An updated outlook on autophagy mechanism and how it supports acute myeloid leukemia maintenance
- Metformin reduces tumor burden and splenomegaly in JAK2V617F murine models
- Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells
- Padronização de modelo xenográfico sistêmico de leucemia linfoide aguda
- The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
